Alnylam Pharmaceuticals Inc
NASDAQ: ALNY
$274.46
+$4.09 (+1.5%)
Closing Price on September 17, 2024
ALNY Articles
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Tuesday. AECOM Technology Corporation (NYSE: ACM) Cut to Underperform at BofA/ML....
Published:
Last Updated:
The three major US stock indexes opened slightly higher this morning, but the DJIA almost immediately turned south and remained in negative territory all session. The Nasdaq composite and S&P 500...
Published:
Last Updated:
Biotech is about to become even less of a diversified sector due to mergers and acquisitions. Genzyme Corporation (NASDAQ: GENZ) and Cephalon Inc. (NASDAQ: CEPH) will end up accounting for about $30...
Published:
Last Updated:
Here are some of the top stories affecting key drug and biotech stocks this Friday. We also have links through to more detailed coverage and analysis at BioHealthInvestor.com: Biogen Idec Inc....
Published:
Here are some of the top stories affecting key drug and biotech stocks that have links through to more in-depth coverage and analysis today at the website BioHealthInvestor.com: Rigel Pharmaceuticals...
Published:
Here are some of the top stories affecting key drug and biotech stocks that are covered in-depth today at BioHealthInvestor.com: Cigna corp. (NYSE: CI), Aetna Inc. (NYSE: AET), and other managed care...
Published:
Alnylam (Nasdaq: ALNY) leads a short list of some of the fastest-growing biotech stocks where analyst estimate revisions continue to rise. BioHealth Investor began by analyzing 171 stocks in the...
Published:
Last Updated:
These are some of the top pre-market analyst upgrades and positive research calls we have seen from Wall Street research calls early this Wednesday morning: Alnylam (ALNY) Started as Buy at Jefferies...
Published:
These are some of the early analyst downgrades or negative calls we are seeing this Wednesday in early pre-market hours: Advance Auto Parts (AAP) Cut to Neutral at JPMorgan. Alnylam Pharma (ALNY)...
Published:
We just saw a report out of Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) that may get traders moving on both sides of the stock. The company has just announced that management will not be presenting...
Published:
Last Updated:
Below are some of the news items affecting shares of biotech stocks: Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) is enjoying upgrades after a positive earnings release Thursday. The company’s...
Published:
Last Updated:
Alnylam Pharmaceuticals (ALNY), an RNAi therapeutics company, has signed a huge license with Roche which could be worth as much as $1 billion The small company had total revenue fo $26 million last...
Published: